Ear Wax Build-up Liquid
NDC Package 55714-2428-2
Package Information
Ear Wax Build-up (elaps corallinus, alumina, carbo veg., causticum, conium, graphites, kali bic., kali mur., lachesis, lycopodium, petroleum, pulsatilla, sabadilla, sepia, silicea, spongia, verbascum, viola odorata) liquids is formulated for associated symptoms such as dryness, itching, hearing difficulties and excess wax accumulation. This formulation utilizes a liquid delivery system. Marketed by Newton Laboratories, Inc., this product is identified by NDC 55714-2428.
Identification & Billing
Clinical Specifications
- ACTIVATED CHARCOAL 15 [hp_X]/mL
- ALUMINUM OXIDE 15 [hp_X]/mL
- CAUSTICUM 15 [hp_X]/mL
- CONIUM MACULATUM FLOWERING TOP 15 [hp_X]/mL
- GRAPHITE 15 [hp_X]/mL
- LACHESIS MUTA VENOM 15 [hp_X]/mL
- LIQUID PETROLEUM 15 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 15 [hp_X]/mL
- MICRURUS CORALLINUS VENOM 30 [hp_X]/mL
- POTASSIUM CHLORIDE 15 [hp_X]/mL
- POTASSIUM DICHROMATE 15 [hp_X]/mL
- PULSATILLA VULGARIS 15 [hp_X]/mL
- SCHOENOCAULON OFFICINALE SEED 15 [hp_X]/mL
- SEPIA OFFICINALIS JUICE 15 [hp_X]/mL
- SILICON DIOXIDE 15 [hp_X]/mL
- SPONGIA OFFICINALIS SKELETON, ROASTED 15 [hp_X]/mL
- VERBASCUM THAPSUS 15 [hp_X]/mL
- VIOLA ODORATA 15 [hp_X]/mL
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 55714 - Newton Laboratories, Inc.
- 55714-2428 - Ear Wax Build-up
- 55714-2428-2 - 50 mL in 1 BOTTLE, GLASS
- 55714-2428 - Ear Wax Build-up
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (55714-2428). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55714-2428-2 identifies a specific commercial package of 50 ml in 1 bottle, glass of Ear Wax Build-up, a human over the counter drug labeled by Newton Laboratories, Inc.. This liquid is formulated for oral use and contains activated charcoal; aluminum oxide; causticum; conium maculatum flowering top; graphite; lachesis muta venom; liquid petroleum; lycopodium clavatum spore; micrurus corallinus venom; potassium chloride; potassium dichromate; pulsatilla vulgaris; schoenocaulon officinale seed; sepia officinalis juice; silicon dioxide; spongia officinalis skeleton, roasted; verbascum thapsus; viola odorata as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Newton Laboratories, Inc. on January 31, 2019. The current certification is valid through December 31, 2026.
How is this Newton Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55714242802. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.